Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnesium pills could help you sleep better, small study hints

NCT ID NCT07359612

Symptom relief Sponsor: Northumbria University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking 250 mg of magnesium daily for 8 weeks can improve sleep quality in healthy adults aged 18–39 who have low magnesium levels and feel they sleep poorly. Researchers will measure sleep using activity trackers and sleep diaries, along with mood and diet questionnaires. The goal is to see if magnesium helps general sleep health, not just insomnia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Magnesium 250 mg dietary supplement
What this could lead to
If it works, this could point toward a simple, low-cost way to improve sleep health in people with low magnesium levels.
What could go wrong
This is a small, early-stage study (65 people) with no placebo group, so results may not be reliable or apply to everyone. Magnesium may cause mild stomach upset.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 65 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 39 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy male or female adult between the ages of 18 and 39 years of age. * Have a stable sleep/wake schedule (bedtime between 9pm and 1am and wake time between 6am and 10am at least 5 nights per week) * Are a fluent English speaker * Diet which is low in magnesium * Self-identify as a poor sleeper (i.e. poor sleep quality or unrefreshing sleep). Exclusion Criteria: * Have symptoms of COVID-19 * Display evidence of current or recent sleep disorders (e.g. sleep apnea, insomnia, circadian rhythm disorders); an initial screening for sleep disorders will be conducted using the Sleep Disorders Screening Checklist - 25 (SDS-CL). Have a history of seizures or epilepsy * Have recently (within the last 12 weeks) had an infection and/or used antibiotic medication * Are pregnant, seeking to become pregnant or lactating * Are a shift worker or a recent history of shift work in the previous 6 months * Are participating in other intervention research trials * Have experienced travel across multiple time zones within the last three months or will be experiencing travel across multiple time zones during the study. * Have recently been diagnosed and/or treated for a mental health or substance use disorder. * Are currently unwell with anything that impacts sleep. * Are taking any medication which has a sedative effect * Are currently using medication which affects the central nervous system. * Are currently misusing alcohol or drugs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep health

Contacts and locations

Locations

  • Northumbria Sleep Research, Northumbria University

    Newcastle, NE1 8ST, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.